Results 81 to 90 of about 10,900 (261)
BMC Pediatrics, 2019 Background Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing
Roseane Porfírio de Souza +3 more
doaj +1 more source
Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity [PDF]
, 2017 Indexación: Web of Science; Scopus.The Human Respiratory Syncytial Virus (hRSV) is a major cause of acute lower respiratory tract infections (ARTIs) and high rates of hospitalizations in children and in the elderly worldwide.
Alexis M. Kalergis +9 more
core +2 more sources
Immunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.ABSTRACT Background Viral‐respiratory infections are the most prevalent illness among humans. A viral infection affecting lower respiratory tract infections (LRTI) is a critical health concern worldwide. The COVID‐19 pandemic has significantly impacted respiratory health, particularly in individuals with asthma.
Mandana Akhavan +2 more
wiley +1 more source
International Journal of Pediatrics, 2014 Infection with respiratory syncytial virus (RSV) is one of the major causes globally of childhood respiratory morbidity and hospitalization. Palivizumab, a humanized monoclonal antibody, has been recommended for high risk infants to prevent severe RSV ...
Nusrat Homaira +3 more
doaj +1 more source
Caratteristiche farmacologiche e uso clinico del Palivizumab nel trattamento dell’infezione dal virus respiratorio sinciziale [PDF]
, 2016 Uno dei principali patogeni del tratto inferiore respiratorio nei bambini sotto i 2 anni è il virus respiratorio sinciziale (RSV). Nel 2015 fu stimato dall’OMS che erano presenti circa 64 milioni di infezioni l’anno e 160mila morti in tutto il mondo ...
SASSETTI, FILIPPO
core
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus [PDF]
, 2006 The mechanism by which respiratory syncytial virus (RSV) suppresses T-cell proliferation to itself and other antigens is poorly understood. We used monocyte-derived dendritic cells (MDDC) and CD4 T cells and measured [(3)H]thymidine incorporation to ...
Chi, Bo +13 more
core +1 more source
Medicine, 2021 Supplemental Digital Content is available in the text Abstract Respiratory syncytial virus (RSV) infection is an important cause of hospitalization in infants and young children. Monthly administration of palivizumab during the RSV season is effective in
Akiko Kamori +7 more
semanticscholar +1 more source
Pediatric Pulmonology, Volume 61, Issue 2, February 2026.ABSTRACT Introduction Bronchiolitis is the leading cause of infant hospitalizations worldwide, primarily driven by respiratory syncytial virus (RSV). Methods This multicenter retrospective comparative study assessed the impact of immunoprophylaxis with nirsevimab against RSV on bronchiolitis‐related hospitalizations in Italy during the 2024–2025 winter
Sergio Ghirardo +28 more
wiley +1 more source
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease [PDF]
, 2016 INTRODUCTION: The REGAL (RSV evidence-a geographical archive of the literature) series provide a comprehensive review of the published evidence in the field of respiratory syncytial virus (RSV) in Western countries over the last 20 years.
Bosco Paes +7 more
core +1 more source
Biotechnology Progress, Volume 42, Issue 1, January/February 2026.Abstract Key hydrodynamic‐related parameters such as volumetric power input (P/V), impeller configuration, aeration strategy, and maximum gas sparge rate, as well as an appropriate feeding strategy, must be carefully selected to improve production yields in bioreactor.
Lucas Lemire +5 more
wiley +1 more source